The Filing Desk

Merit Medical Systems vs Organogenesis

Merit Medical Systems MMSI · Organogenesis ORGO · Health Care Supplies

Merit Medical Systems reported revenue of $1.5 billion in fiscal 2025, 2.7 times Organogenesis' $564 million in fiscal 2025. Merit Medical Systems' revenue grew 11.8% in its latest year, and Organogenesis' grew 17.0%. Merit Medical Systems had an operating margin of 12.2%, against 7.9% at Organogenesis. Free cash flow was $216 million at Merit Medical Systems and −$24 million at Organogenesis.

Side by side

Merit Medical SystemsOrganogenesis
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$1.5B$564M
Revenue growth11.8%17.0%
Revenue growth a year, last 5 years9.5%10.8%
Gross margin48.7%—
Operating margin12.2%7.9%
Net margin8.5%6.6%
Free cash flow$216M−$24M
Free cash flow margin14.2%−4.3%
Return on capital7.7%—
Net debt to EBITDA0.9x—
Dividends and buybacks$0M$0M
Change in diluted share count1.8%−1.1%
Last close$84.41$0.79
P/E at the last close31.6×—
Insider trades, last 12 monthsbought $573,303, sold $9.5 millionbought $40,100, sold $2.6 million
Piotroski F-score8 of 9—
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Merit Medical SystemsOrganogenesis
Operating margin
Percent of revenue
Merit Medical SystemsOrganogenesis
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Merit Medical SystemsOrganogenesis

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Merit Medical Systems and Organogenesis pages.